Cell line · CVCL_0294

HEC-1-B

Cancer cell line, Homo sapiens. Type II endometrial adenocarcinoma. 30 papers.

4 sourcescell-lines-2026-11-14-0.1.0

Cite this record

ConductScience Library. HEC-1-B. Cell lines, record CVCL_0294. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0294

On this page

Cell line

As Cellosaurus gives it.

Name: HEC-1-B
Accession: CVCL_0294
RRID: RRID:CVCL_0294
Synonyms: Hec-1-B, HEC-1B, Hec-1b, HEC1-B, HEC1B, Hec1B
Species: Homo sapiens (Human)
Sex: Female
Age at sampling: 71Y
Category: Cancer cell line
Diseases: Type II endometrial adenocarcinoma (NCIt C39749)
Derived from: Endometrium (in situ)
Parent: HEC-1-A (CVCL_0293)
Entry created: 2012-04-04
Entry updated: 2026-06-25

Source Cellosaurus

Problems0

Cellosaurus records no problem for this cell line.

None in this release.

Papers30

Paper	Journal	Year	How we know	Source
p190A/ARHGAP35 and p190B/ARHGAP5 proteins in endometrial cancer: a novel cancer-relevant paralog interplay.	Mol Oncol	2026	Its Methods give the RRID and name the line	PubMed
Targeting CD24 Activates Macrophages to Reduce Tumor Burden in Preclinical Models of Solid Tumors.	Clin Cancer Res	2026	Its Methods give the RRID and name the line	PubMed
Loss of cold shock domain-containing protein E1 (CSDE1) function enhances mRNA stability of interleukin-6 and promotes malignant transformation in endometrial cancer cells.	Cell Commun Signal	2026	Its Methods give the RRID and name the line	PubMed
NSD1-Mediated PPARγ Methylation Enhances PTEN Activity to Suppress Glycolysis and Tumor Progression in Endometrial Cancer.	Cancer Res	2026	Its Methods give the RRID and name the line	PubMed
Phase Ib Study of Pembrolizumab in Combination with Intratumoral Injection of Clostridium novyi-NT in Patients with Advanced Solid Tumors.	Clin Cancer Res	2025	Its Methods give the RRID and name the line	PubMed
Assessment of NUDT5 in Endometrial Carcinoma: Functional Insights, Prognostic and Therapeutic Implications.	Biomedicines	2025	Its Methods give the RRID and name the line	PubMed
Lipid-Metabolism-Related Gene Signature Predicts Prognosis and Immune Microenvironment Alterations in Endometrial Cancer.	Biomedicines	2025	Its Methods give the RRID and name the line	PubMed
Functional Profiling of p53 and RB Cell Cycle Regulatory Proficiency Suggests Mechanism-Driven Molecular Stratification in Endometrial Carcinoma.	Cancer Res Commun	2025	Its Methods give the RRID and name the line	PubMed
Identification of a TNIK-CDK9 Axis as a Targetable Strategy for Platinum-Resistant Ovarian Cancer.	Mol Cancer Ther	2025	Its Methods give the RRID and name the line	PubMed
A negatively charged region within carboxy-terminal domain maintains proper CTCF DNA binding.	iScience	2024	Its Methods give the RRID and name the line	PubMed

1 to 10 of 30

See all 30 papers

Relatives18

Relation	Cell line	Accession	Source
Parent	HEC-1-A	CVCL_0293	Cell lines
Derived from it	EDITGENE HEC-1-B-CopGFP	CVCL_F6C4	Cell lines
Derived from it	EDITGENE HEC-1-B-FLUC	CVCL_F5VG	Cell lines
Derived from it	EDITGENE SPDEF Knockout HEC-1-B Cell Line	CVCL_F5C1	Cell lines
Derived from it	HEC-1-B-Cas9-580	CVCL_XC84	Cell lines
Derived from it	HEC-1-B-Cas9-581	CVCL_XC85	Cell lines
Derived from it	HEC-1-B-Cas9-582	CVCL_XC86	Cell lines
Derived from it	HEC-1-B-Cas9-583	CVCL_XC87	Cell lines
Derived from it	HEC-1-B-Cas9-584	CVCL_XC88	Cell lines
Derived from it	HEC-1-B-Cas9-585	CVCL_XC89	Cell lines

1 to 10 of 18

See all 18 relatives

Cell banks9

Cell bank	Catalog number	Status	Source
ATCC	HTB-113		ATCC
CCTCC	GDC0129		Cellosaurus
CLS	305095		CLS
EDITGENE	EDC00252		EDITGENE
Hysigen	TCH-C189		Hysigen
JCRB	JCRB1193		JCRB
JCRB	NIHS0480	Discontinued	Cellosaurus
KCB	KCB 200551YJ		Cellosaurus
Ubigene	YC-C108		Ubigene

Data dates

The date of each source this release read.

Cellosaurus: 2026-10-22; Cellosaurus
PubMed Central's articles: 2026-11-12; PubMed Central's articles
Our copy of PubMed: 2026-11-06; Our copy of PubMed

Sources 4

CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
PubMedNLM's terms

Each source's terms

CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
PubMedNLM's terms

Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.

For software

Read this cell line from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/cell-lines/v1/CVCL_0294

GET https://conductscience.org/api/cell-lines/v1/CVCL_0294/papers?page=2

API reference For AI assistants